Advertisement

Contemporary Management of Recurrent Respiratory Papillomatosis in Children

  • Sarah N. Bowe
  • Christopher J. Hartnick
Chapter

Abstract

Recurrent respiratory papillomatosis (RRP) is a rare disease, yet represents the most common benign neoplasm of the larynx in children. While the primary symptom is hoarseness, these changes in voice may go unnoticed with potentially devastating consequences due to airway obstruction. This chapter will focus on the contemporary management of RRP in children. Virology will be discussed briefly, focusing specifically on disease severity. Clinical features, including history, physical exam, and airway endoscopy with staging assessment, will be provided. The main emphasis will be directed at surgical management including cold-steel, microdebrider, and laser techniques, as well as anesthesia considerations. A brief discussion on combination therapy, in which adjuvant treatment is paired with surgical management, will be reviewed. Finally, we will present novel opportunities for personalized medicine using cell culture techniques on tumor specimens.

Keywords

Pediatric Human papillomavirus (HPV) Laryngeal papillomatosis Recurrent respiratory papillomatosis (RRP) Juvenile-onset recurrent respiratory papillomatosis (JORRP) Surgery Laser Microdebrider Treatment Management 

References

  1. Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope. 1987;97:678–85.CrossRefPubMedGoogle Scholar
  2. Abramson AL, DiLorenzo TP, Steinberg BM. Is papillomavirus detectable in the plume of laser-treated laryngeal papilloma? Arch Otolaryngol Head Neck Surg. 1990;116:604–7.CrossRefPubMedGoogle Scholar
  3. Behar PM, Todd NW. Gender and intra-observer agreement about laryngoscopy of papilloma. Int J Pediatr Otorhinolaryngol. 1999;50:125–31.CrossRefPubMedGoogle Scholar
  4. Bergler W, Honig M, Gotte K, Petroianu G, Hormann K. Treatment of recurrent respiratory papillomatosis with argon plasma coagulation. J Laryngol Otol. 1997;111:381–4.CrossRefPubMedGoogle Scholar
  5. Borkowski G, Sommer P, Stark T, Sudhoff H, Luckhaupt H. Recurrent respiratory papillomatosis associated with gastroesophageal reflux disease in children. Eur Arch Otorhinolaryngol. 1999;256:370–2.CrossRefPubMedGoogle Scholar
  6. Bower CM, Waner M, Flock S, Schaeffer R. Flash pump dye laser treatment of laryngeal papillomas. Ann Otol Rhinol Laryngol. 1998;107:1001–5.CrossRefPubMedGoogle Scholar
  7. Buchinsky FJ, Donfack J, Derkay CS, et al. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One. 2008;3:e2263.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Burns JA, Zeitels SM, Akst LM, Broadhurst MS, Hillman RE, Anderson R. 532 nm pulsed potassium-titanyl-phosphate laser treatment of laryngeal papillomatosis under general anesthesia. Laryngoscope. 2007;117:1500–4.CrossRefPubMedGoogle Scholar
  9. Cole RR, Myer CM 3rd, Cotton RT. Tracheotomy in children with recurrent respiratory papillomatosis. Head Neck. 1989;11:226–30.CrossRefPubMedGoogle Scholar
  10. Derkay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121:1386–91.CrossRefPubMedGoogle Scholar
  11. Derkay CS, Faust RA. Recurrent respiratory papillomatosis. In: Lesperance MM, Flint PW, editors. Cummings pediatric otolaryngology. Philadelphia, PA: Elsevier Saunders; 2015. p. 332–47.Google Scholar
  12. Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope. 1998;108:935–7.CrossRefPubMedGoogle Scholar
  13. Derkay CS, Hester RP, Burke B, Carron J, Lawson L. Analysis of a staging assessment for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2004;68:1493–8.CrossRefPubMedGoogle Scholar
  14. El-Bitar MA, Zalzal GH. Powered instrumentation in the treatment of recurrent respiratory papillomatosis: an alternative to the carbon dioxide laser. Arch Otolaryngol Head Neck Surg. 2002;128:425–8.CrossRefPubMedGoogle Scholar
  15. Faust RA. Childhood voice disorders: ambulatory evaluation and operative diagnosis. Clin Pediatr. 2003;42:1–9.CrossRefGoogle Scholar
  16. Fouzas S, Priftis KN, Anthracopoulos MB. Pulse oximetry in pediatric practice. Pediatrics. 2011;128:740–52.CrossRefPubMedGoogle Scholar
  17. Hallden C, Majmudar B. The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminate. J Reprod Med. 1986;31:804–7.PubMedGoogle Scholar
  18. Hallmo P, Naess O. Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon. Eur Arch Otorhinolaryngol. 1991;248:425–7.CrossRefPubMedGoogle Scholar
  19. Hartnick CJ, Boseley ME, Franco RA Jr, Cunningham MJ, Pransky S. Efficacy of treating children with anterior commissure and true vocal fold respiratory papilloma with the 585-nm pulsed-dye laser. Arch Otolaryngol Head Neck Surg. 2007;133:127–30.CrossRefPubMedGoogle Scholar
  20. Hester RP, Derkay CS, Burke BL, Lawson ML. Reliability of a staging assessment system for recurrent respiratory papillomatosis. J Pediatr Otorhinolaryngol. 2003;67:505–9.CrossRefGoogle Scholar
  21. Holland BW, Koufman JA, Postma GN, McGuirt WF Jr. Laryngopharyngeal reflux and laryngeal web formation in patients with pediatric recurrent respiratory papillomas. Laryngoscope. 2002;112:1926–9.CrossRefPubMedGoogle Scholar
  22. Kashima H, Leventhal B, Mounts P, Papilloma Study Group. Scoring system to assess severity and course in recurrent respiratory papillomatosis. In: Howley PM, Broker TR, editors. Papillomaviruses: molecular and clinical aspects. New York, NY: Alan R Liss, Inc.; 1985. p. 125–35.Google Scholar
  23. Kashima HK, Kessis T, Mounts P, Shah K. Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. 1991;104:191–5.CrossRefPubMedGoogle Scholar
  24. Kashima H, Mounts P, Leventhal B, Hruban RH. Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 1993;102:580–3.CrossRefPubMedGoogle Scholar
  25. Kuhar DT. Respiratory protection to prevent potential transmission of human papillomavirus during surgical procedures that generate smoke. 2013. http://c.ymcdn.com/sites/www.cste.org/resource/dynamic/forums/20131112_151658_22377.pdf. Accessed 15 Jun 2016.
  26. Lusk RP, McCabe BF, Mixon JH. Three-year experience of treating recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 1987;96:158–62.CrossRefPubMedGoogle Scholar
  27. Maturo S, Hartnick CJ. Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience. Arch Otolaryngol Head Neck Surg. 2010;136:561–5.CrossRefPubMedGoogle Scholar
  28. Maturo S, Hartnick CJ. Juvenile-onset recurrent respiratory papillomatosis. Adv Otorhinolaryngol. 2012;73:105–8.PubMedGoogle Scholar
  29. McMillan K, Shapshay SM, McGilligan JA, Wang Z, Rebeiz EE. A 585-nanometer pulsed dye laser treatment of laryngeal papillomas: preliminary report. Laryngoscope. 1998;108:968–72.CrossRefPubMedGoogle Scholar
  30. Mounts P, Kashima H. Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope. 1984;94:28–33.CrossRefPubMedGoogle Scholar
  31. Myer CM III, Willging JP, McMurray S, Cotton RT. Use of a laryngeal micro resector system. Laryngoscope. 1999;109:1165–6.CrossRefPubMedGoogle Scholar
  32. Padayachee A, Prescott CA. Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The red cross war memorial Children’s hospital experience 1982–1988. Int J Pediatr Otorhinolaryngol. 1993;26:141–7.CrossRefPubMedGoogle Scholar
  33. Pasquale K, Wiatrak B, Woolley A, Lewis L. Microdebrider versus CO2 laser removal of recurrent respiratory papillomas: a prospective analysis. Laryngoscope. 2003;113:139–43.CrossRefPubMedGoogle Scholar
  34. Patel N, Rowe M, Tunkel D. Treatment of recurrent respiratory papillomatosis in children with the microdebrider. Ann Otol Rhinol Laryngol. 2003;112:7–10.CrossRefPubMedGoogle Scholar
  35. Quick CA, Watts SL, Krzyzek RA, Faras AJ. Relationship between condylomata and laryngeal papillomata: clinical and molecular virological evidence. Ann Otol Rhinol Laryngol. 1980;89:467–71.CrossRefPubMedGoogle Scholar
  36. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol. 2001;4:68–72.CrossRefPubMedGoogle Scholar
  37. Ribatti D. The discovery of antiangiogenic molecules: a historical review. Curr Pharm Des. 2009;15:345–52.CrossRefPubMedGoogle Scholar
  38. Rimell FL, Shoemaker DL, Pou AM, et al. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope. 1997;107:915–8.CrossRefPubMedGoogle Scholar
  39. Rogers DJ, Ojha S, Maurer R, Hartnick CJ. Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children. JAMA Otolaryngol Head Neck Surg. 2013;139:496–501.CrossRefPubMedGoogle Scholar
  40. Schraff S, Derkay CS, Burke B, Lawson L. American Society of Pediatric Otolaryngology members’ experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg. 2004;130:1039–42.CrossRefPubMedGoogle Scholar
  41. Shah KV, Stern WF, Shah FK, Bishai D, Kashima HK. Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J. 1998;17:372–6.CrossRefPubMedGoogle Scholar
  42. Shapiro AM, Rimell FL, Shoemaker D, Pou A, Stool SE. Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: the Children’s Hospital of Pittsburgh experience. Ann Otol Rhinol Laryngol. 1996;105:1–5.CrossRefPubMedGoogle Scholar
  43. Soldatski IL, Onufrieva EK, Steklov AM, Schepin NV. Tracheal, bronchial, and pulmonary papillomatosis in children. Laryngoscope. 2005;115:1848–54.CrossRefPubMedGoogle Scholar
  44. Swanson VC, Taneja PA, Gries H, Koh J. Anesthesia in pediatric otolaryngology. In: Lesperance MM, Flint PW, editors. Cummings pediatric otolaryngology. Philadelphia, PA: Elsevier Saunders; 2015. p. 21–38.Google Scholar
  45. Todd NW. Observer agreement about laryngoscopic assessment of papilloma. Int J Pediatr Otorhinolaryngol. 1997;41:37–46.CrossRefPubMedGoogle Scholar
  46. Uloza V. The course of laryngeal papillomatosis treated by endolaryngeal microsurgery. Eur Arch Otorhinolaryngol. 2000;257:498–501.CrossRefPubMedGoogle Scholar
  47. Valdez TA, McMillan K, Shapshay SM. A new laser treatment for vocal cord papilloma—585-nm pulsed dye. Otolaryngol Head Neck Surg. 2001;124:421–5.CrossRefPubMedGoogle Scholar
  48. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope. 2004;114:1–23.CrossRefPubMedGoogle Scholar
  49. Yuan H, Myers S, Wang J, et al. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med. 2012;367:1220–7.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Zeitels SM, Sataloff RT. Phonomicrosurgical resection of glottal papillomatosis. J Voice. 1999;13:123–7.CrossRefPubMedGoogle Scholar
  51. Zeitels SM, Franco RA Jr, Dailey SH, Burns JA, Hillman RE, Anderson RR. Office-based treatment of glottal dysplasia and papillomatosis with the 585-nm pulse dye laser and local anesthesia. Ann Otol Rhinol Laryngol. 2004;113:265–76.CrossRefPubMedGoogle Scholar
  52. Zeitels SM, Akst LM, Burns JA, et al. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol. 2006;115:679–85.CrossRefPubMedGoogle Scholar
  53. Zeitels SM, Lopez-Guerra G, Burns JA, Lutch M, Friedman AM, Hillman RE. Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis. Ann Otol Rhinol Laryngol Suppl. 2009;201:1–13.PubMedGoogle Scholar
  54. Zeitels SM, Barbu AM, Landau-Zemer T, et al. Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study. Ann Otol Rhinol Laryngol. 2011;120:627–34.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Division of Pediatric Otolaryngology, Department of Otology and LaryngologyMassachusetts Eye and Ear InfirmaryBostonUSA

Personalised recommendations